Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...
The ASG informed the court today that if any medical treatment wants to be extended or warranted it will be immediately furnished to the detenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results